Hôpital Sainte-Marguerite

Marseille 13274

0 studies enrolling now · 2 studies all time

What they study most

HIV-1-infection, Metastatic Melanoma

Studies at this site

• Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance — Running, not enrolling
• Masitinib in Non-Resectable or Metastatic Stage 3/4 Melanoma Carrying a Mutation in the Juxta Membrane Domain of c-Kit — Stopped early